This post is part of a paid sponsorship by Shire Pharmaceuticals. All opinions are my own.
He’s so bright. He started talking at 7 months! Why isn’t he in a program for gifted children? His maturity and intelligence really shine above his peers.
These are just a sampling of the many gushing compliments I continually heard about my son. Until college. At the age of 18, he was diagnosed by a doctor with Attention Deficit Hyperactivity Disorder (ADHD).
ADHD is a chronic mental disorder which includes symptoms of inattention, hyperactivity and impulsivity. ADHD symptoms may occur at home, work, school, and/or in social settings. Diagnosis can only be made by a trained healthcare professional based on a complete history and evaluation, and is formed utilizing criteria specified in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5®). Presently, approximately 10.5 million adults and 6.4 million children in the United States (U.S.) are living with ADHD. Approximately 50 to 66 percent of children with ADHD in childhood will continue to have symptoms as adults.
Since my own son’s diagnosis, I have beat myself up mightily for not realizing this. Seeking answers, I recently completed my doctorate semester final in pharmacology. I learned so much more about ADHD and the various treatment options including Mydayis® (mixed salts of a single-entity amphetamine product).
On June 20, 2017, the U.S. Food and Drug Administration (FDA) approved Mydayis for the treatment of ADHD in patients 13 years and older. Mydayis is not for use in children 12 years and younger. Mydayis offers an extended-release treatment option for appropriate patients with ADHD.
Remember, Mydayis and other stimulant medicines have a high chance for abuse and dependence. Your doctor should check you or your child for signs of abuse and dependence before and during treatment with Mydayis. It is important to know that Mydayis is a federally controlled substance because it contains amphetamine. You’ll find more important safety information below.
Today there is a more advanced awareness and understanding of ADHD and the individual management needs of these individuals, young and old. For family members, such as myself, staying fully informed is crucial. Though there is presently no cure for ADHD, accepted management options include educational approaches and counseling, and perhaps behavioral intervention and/or medication. It’s important to talk with your doctor to determine what treatment option(s) may be right for you. Though medication may not be appropriate for everyone, Mydayis is now a treatment option for ADHD for patients 13 years and older. Not for use in children 12 years and younger.
Learn more at mydayis.com
DSM-5 is a registered trademark of the American Psychiatric Association.